.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
McKinsey
Daiichi Sankyo
Moodys
QuintilesIMS
Express Scripts
Julphar
Cipla
Mallinckrodt
Chubb

Generated: September 22, 2017

DrugPatentWatch Database Preview

Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) - Generic Drug Details

« Back to Dashboard

What are the generic sources for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) and what is the scope of trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) freedom to operate?

Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
is the generic ingredient in nine branded drugs marketed by Forest Pharms, Bristol Myers Squibb, Wyeth Ayerst, Lilly, Lederle, Lannett, Impax Labs, Alpharma Us Pharms, Purepac Pharm, and Pal Pak, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)

Tradenames:9
Patents:0
Applicants:10
NDAs:11
Clinical Trials: see list21
Drug Prices:see low prices
DailyMed Link:trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
NEOTRIZINE
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
SUSPENSION;ORAL006317-012Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Forest Pharms
SULFALOID
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
TABLET;ORAL080099-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Forest Pharms
SULFALOID
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
SUSPENSION;ORAL080100-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pal Pak
TRIPLE SULFOID
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
TABLET;ORAL080094-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
NEOTRIZINE
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
TABLET;ORAL006317-011Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
SULFA-TRIPLE #2
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
TABLET;ORAL080079-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
TERFONYL
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
TABLET;ORAL006904-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
TRIPLE SULFAS
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
TABLET;ORAL006920-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
TRIPLE SULFAS
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
SUSPENSION;ORAL006920-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
TRIPLE SULFA
trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
TABLET;ORAL080086-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Covington
Cerilliant
QuintilesIMS
Daiichi Sankyo
Julphar
Chubb
Farmers Insurance
UBS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot